EZH2介导GATA-4调控miR-29a在骨骼肌发育中的作用机制

基本信息
批准号:81771631
项目类别:面上项目
资助金额:60.00
负责人:臧明玺
学科分类:
依托单位:郑州大学
批准年份:2017
结题年份:2021
起止时间:2018-01-01 - 2021-12-31
项目状态: 已结题
项目参与者:贾欣,施佳辰,戴菲菲,张思,杨明辉,李金霞
关键词:
Polycomb微小RNA表观遗传学调控其他系统发育骨骼肌发育蛋白复合体
结项摘要

Skeletal muscle development is a complex process which occurred in an orderly way, but the exact mechanism by which skeletal muscle development is regulated has not been fully elucidated. We found that GATA-4 not only promoted the proliferation and differentiation of C2C12 myoblasts, but also inhibited the expression of miR-29a. Since GATA-4 functions as a transcriptional activator, we speculate that transcription repressors should be involved in this process. Given the Polycomb group proteins are able to mediate gene silencing through the modification of chromatin structure, furthermore, EZH2, a member of the Polycomb protein family, can form protein complexes with GATA-4 and binds to the promoter of miR-29a, we propose the hypothesis that EZH2 play roles in the expression of miR-29a inhibited by GATA-4 during skeletal muscle development. To address the hypothesis, we will first analyze whether EZH2 and GATA-4 bind to the miR-29a promoter, and whether the binding of EZH2 and GATA-4 to the miR-29a promoter is depended on H3K27me3, or can be attributed to heterochromatin during skeletal muscle development. Next, we will analyze which member of Polycomb repressive complex 1 (PRC1) is involved in the above mentioned process, and exerts its effects on skeletal muscle development. These complementary lines of investigation will provide insight to understand the regulatory mechanisms of skeletal muscle development, which could provide more clues for prevention and treatment of congenital dysplasia of skeletal muscle.

骨骼肌的发育过程是复杂而有序的,但其调节机制,目前尚未阐明。我们发现, GATA-4不仅促进成肌细胞C2C12增殖和分化,还抑制miR-29a 的表达。由于GATA-4是转录激活因子,所以推测此过程应该有抑制因子参与。鉴于Polycomb 蛋白复合体能抑制基因表达,并且我们已经证明其关键成员EZH2与GATA-4形成蛋白复合体并结合在miR-29a的启动子区,因此,我们提出了“EZH2介导GATA-4抑制miR-29a表达并在骨骼肌发育中发挥作用” 的假说,并拟进行下列研究:首先,分析在骨骼肌发育中,EZH2与GATA-4在miR-29a启动子区是否结合、是否依赖于H3K27me3、是否归因于异染色质的发生;其次,分析上述过程是否有Polycomb蛋白复合体中PRC1不同组分的参与及对骨骼肌发育的影响。上述研究将进一步阐明骨骼肌发育的分子机理,同时也为防治先天性骨骼肌发育不良提供理论依据。

项目摘要

骨骼肌的发育是一个复杂而有序的过程,但其调节机制,目前尚未阐明。在本研究中,我们首先分析了在骨骼肌发育中,EZH2与GATA-4在miR-29a启动子区是否结合、是否依赖于H3K27me3、是否归因于异染色质的发生;其次,分析上述过程是否有Polycomb蛋白复合体中PRC1不同组分的参与及对骨骼肌发育的影响等。上述研究揭示了GATA-4、EZH2及miR-29a在骨骼肌发育中的作用并探索EZH2介导GATA-4调控miR-29a在骨骼肌发育中的作用机制,在EZH2→GATA-4→miR-29a→骨骼肌发育互动关系及相关分子网络基础和调控机理方面取得突破性进展,同时也为防治骨骼肌发育不良提供理论依据。已发表2篇SCI 论文,还有1篇文章在修稿阶段(Oncogene),1篇文章已投稿至Basic Research in Cardiology,另一篇文章在投稿前完善阶段。课题主持人于2018年获河南省高层次人才特殊支持“中原千人计划”——中原基础研究领军人才,2020年获河南省政府特殊津贴和河南省高层次人才认定(B类),于2021年获河南省优秀专家。培养研究生6人。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

丙二醛氧化修饰对白鲢肌原纤维蛋白结构性质的影响

丙二醛氧化修饰对白鲢肌原纤维蛋白结构性质的影响

DOI:10.7506/spkx1002-6630-20190411-143
发表时间:2020
2

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
3

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

DOI:
发表时间:2021
4

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
5

内质网应激在抗肿瘤治疗中的作用及研究进展

内质网应激在抗肿瘤治疗中的作用及研究进展

DOI:10.3969/j.issn.1001-1978.2021.12.004
发表时间:2021

相似国自然基金

1

Myostatin调控的miRNAs在骨骼肌发育中的功能及表达调控的分子机制

批准号:31030041
批准年份:2010
负责人:朱大海
学科分类:C0602
资助金额:210.00
项目类别:重点项目
2

miR-29a在精原细胞分化过程中的作用及机制

批准号:31900598
批准年份:2019
负责人:姚广新
学科分类:C1206
资助金额:24.00
项目类别:青年科学基金项目
3

miR-29a影响骨骼肌胰岛素敏感性的分子机制

批准号:81300654
批准年份:2013
负责人:曾玉
学科分类:H0707
资助金额:23.00
项目类别:青年科学基金项目
4

EZH2介导的自噬在脓毒症急性肾损伤中的作用机制研究

批准号:81800681
批准年份:2018
负责人:梅淑钦
学科分类:H0511
资助金额:20.00
项目类别:青年科学基金项目